IRIDEX Corp (IRIX)

14.74
0.08 0.54
NASDAQ : Health Care
Prev Close 14.82
Open 14.44
Day Low/High 14.44 / 15.22
52 Wk Low/High 6.45 / 16.64
Volume 25.73K
Avg Volume 46.20K
Exchange NASDAQ
Shares Outstanding 10.12M
Market Cap 147.43M
EPS 0.10
P/E Ratio 208.14
Div & Yield N.A. (N.A)

Latest News

IRIDEX Announces Cyclo G6™ With MicroPulse® P3 Clinical Data Presented At ARVO And ASCRS Annual Meetings

IRIDEX Announces Cyclo G6™ With MicroPulse® P3 Clinical Data Presented At ARVO And ASCRS Annual Meetings

Data underscore safety and efficacy of non-invasive tissue-sparing technology in patients with glaucoma

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BMTC, BWINA, FLR, JOUT, K, LND, OXY, PACD, PCTY, RF, SFM, SMLP, SPGI, TAHO, TK, TRNO Downgrades: AHT, ALDW, ALJ, BELFA, BELFB, ERA, IRCP, IRIX, KATE, MTW, POPE, QDEL, QLGC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

IRIDEX Receives CE Mark For Cyclo G6™ Laser System For The Treatment Of Multiple Stages Of Glaucoma

IRIDEX Receives CE Mark For Cyclo G6™ Laser System For The Treatment Of Multiple Stages Of Glaucoma

European Roll-Out Follows Successful Launch in US Market; System Placements and Utilization Surpass Expectations

IRIDEX Announces Preliminary Unaudited Revenues For 2015 Fourth Quarter And Full Year

IRIDEX Announces Preliminary Unaudited Revenues For 2015 Fourth Quarter And Full Year

Year-End Strength in Both Glaucoma and Retinal Laser Systems and Procedures

Insider Trading Alert - SWHC, HES And IRIX Traded By Insiders

Insider Trading Alert - SWHC, HES And IRIX Traded By Insiders

Stocks with insider trader activity include SWHC, HES and IRIX

Insider Trading Alert - ININ, GSAT And IRIX Traded By Insiders

Insider Trading Alert - ININ, GSAT And IRIX Traded By Insiders

Stocks with insider trader activity include ININ, GSAT and IRIX

Insider Trading Alert - IRIX, SGA And RM Traded By Insiders

Insider Trading Alert - IRIX, SGA And RM Traded By Insiders

Stocks with insider trader activity include IRIX, SGA and RM

IRIDEX Broadens Global Glaucoma Outreach With Novel Eye Pressure Diagnostic Device

IRIDEX Broadens Global Glaucoma Outreach With Novel Eye Pressure Diagnostic Device

Icare's Tonometer for Monitoring Intra-Ocular Pressure Adds to Recurring Revenue Stream

Insider Trading Alert - IRIX, SGA And SNFCA Traded By Insiders

Insider Trading Alert - IRIX, SGA And SNFCA Traded By Insiders

Stocks with insider trader activity include IRIX, SGA and SNFCA

IRIDEX' Total Glaucoma Solution Campaign For US Market To Debut At Annual Congress Of The American Society Of Cataract And Refractive Surgery

IRIDEX' Total Glaucoma Solution Campaign For US Market To Debut At Annual Congress Of The American Society Of Cataract And Refractive Surgery

Solution includes IQ 532™ Laser for Repeatable MicroPulse® Laser Trabeculoplasty and the New Cyclo G6™ System with the Proprietary MicroPulse P3 Disposable

IRIDEX Granted U.S. Patent For Disposable Device For Efficient And Predictable Wound Closure In Eye Surgeries

IRIDEX Granted U.S. Patent For Disposable Device For Efficient And Predictable Wound Closure In Eye Surgeries

New iClip™ Closure Device Focused on Glaucoma with Broadening Applications in Other Specialties of Ophthalmology

IRIDEX Announces First Commercial Sales Of New Cyclo G6™ Glaucoma Laser Systems

IRIDEX Announces First Commercial Sales Of New Cyclo G6™ Glaucoma Laser Systems

Initial Orders Include the Recently Patented MicroPulse® P3 Disposable Probe

IRIDEX To Debut Cyclo G6™ Glaucoma Laser Platform And Present New Clinical Data At The American Glaucoma Society's Annual Meeting

IRIDEX To Debut Cyclo G6™ Glaucoma Laser Platform And Present New Clinical Data At The American Glaucoma Society's Annual Meeting

Laser Platform Supports Family of Consumable Probes and Appliances Including Recently Patented MicroPulse® P3 Disposable

5 Small-Cap Health Care Stocks You Never Heard of But Should Consider for 2015

5 Small-Cap Health Care Stocks You Never Heard of But Should Consider for 2015

The health care equipment and supplies may not seem like the sexiest of places to invest, but the sector has a positive outlook, according to TheStreet Ratings.

IRIDEX Receives FDA Clearance For Cyclo G6™ Laser System For The Treatment Of Multiple Stages Of Glaucoma

IRIDEX Receives FDA Clearance For Cyclo G6™ Laser System For The Treatment Of Multiple Stages Of Glaucoma

MicroPulse® Technology Offers Minimally Invasive, Repeatable Treatment Option that Can Slow Progression of Disease; Delay Surgical Intervention